Daniela Alves da Quinta

Daniela Alves da Quinta

Auto-generated profile, based on publicly available information

Daniela Alves da Quinta

Laboratorio de Terapia Molecular y Celular, Fundación Instituto Leloir-CONICET, Ciudad de Buenos Aires, Argentina

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2025 in Cancer Research Communications
Verified
Journal Article
Open access
DQDaniela Alves da Quinta
Daniela Alves da Quinta
DRDarío Rocha
Darío Rocha
CYCristian Yáñez
Cristian Yáñez
RBRenata Binato
Renata Binato
SLSheila Lima
Sheila Lima
LFLaura Fejerman
Laura Fejerman
This study investigates the relationship between genetic ancestry, breast cancer subtypes, and survival outcomes among 951 locally advanced breast cancer cases from Argentina, Brazil, Chile, Mexico, and Uruguay, participating in the Molecular Profile of Breast Cancer Study. Array-based genotyping and ADMIXTURE analysis were used for genetic ancestry evaluation. Breast cancer subtypes were defined by IHC and the gene expression–based PAM50 algorithm. The distribution of genetic ancestry, including European, Indigenous American (IA), African (AFR), and East Asian components, revealed a heterogeneous genetic admixture across countries, with the highest IA ancestry observed in Chile (30.9%) and Mexico (30.8%). Testing the relationship between genetic ancestry and breast cancer subtypes demonstrated that a 10% increase in European ancestry was significantly associated with a 14% decrease in the odds of developing HER2-enriched breast cancer, after adjustment by age, nodal status, and the AFR component (adj. P = 0.021, luminal A as reference). Accordingly, a 10% increase in IA ancestry was associated with a 21% increase in the probability of having HER2-enriched breast cancer (adj. P = 0.022). IA ancestry also significantly increased overall survival after adjustment by age, nodal status, and AFR ancestry, although this result is controversial and may be affected by the size and heterogeneity of the Molecular Profile Breast Cancer Study cohort. Our research confirms previous findings of a high prevalence of HER2-dependent breast tumors among Hispanic/Latina women and strengthens the hypotheses of the existence of either population-specific genetic variant(s) or of other ancestry-correlated factors that impact HER2 expression in breast cancer consistently across different Latin American regions. Significance: The evidence in this work supports the idea that factors linked to genetic ancestry influence the prevalence of breast cancer subtypes in Latin America, potentially affecting treatment needs in the region.

3 July 2025
Verified
Other
Open access
DQDaniela Alves da Quinta
Daniela Alves da Quinta
DRDarío Rocha
Darío Rocha
CYCristian Yáñez
Cristian Yáñez
RBRenata Binato
Renata Binato
SLSheila Lima
Sheila Lima
LFLaura Fejerman
Laura Fejerman
Univariate and multivariate Cox proportional hazard models for overall survival for every 10% increase of EUR or IA ancestry

3 July 2025
Verified
Other
Open access
DQDaniela Alves da Quinta
Daniela Alves da Quinta
DRDarío Rocha
Darío Rocha
CYCristian Yáñez
Cristian Yáñez
RBRenata Binato
Renata Binato
SLSheila Lima
Sheila Lima
LFLaura Fejerman
Laura Fejerman
By-country epidemiologic and clinical characteristics of the 951 patients of the LACRN-MPBCS included in this study

3 July 2025
Verified
Other
Open access
PDF file
DQDaniela Alves da Quinta
Daniela Alves da Quinta
DRDarío Rocha
Darío Rocha
CYCristian Yáñez
Cristian Yáñez
RBRenata Binato
Renata Binato
SLSheila Lima
Sheila Lima
LFLaura Fejerman
Laura Fejerman
Distribution of immunohistochemistry (IHC) breast cancer subtypes according to the four most prevalent ancestral components in Latin America.

3 July 2025
Verified
Other
Open access
PDF file
DQDaniela Alves da Quinta
Daniela Alves da Quinta
DRDarío Rocha
Darío Rocha
CYCristian Yáñez
Cristian Yáñez
RBRenata Binato
Renata Binato
SLSheila Lima
Sheila Lima
LFLaura Fejerman
Laura Fejerman
Supplementary information and List of LACRN Investigators

3 July 2025
Verified
Other
Open access
DQDaniela Alves da Quinta
Daniela Alves da Quinta
DRDarío Rocha
Darío Rocha
CYCristian Yáñez
Cristian Yáñez
RBRenata Binato
Renata Binato
SLSheila Lima
Sheila Lima
LFLaura Fejerman
Laura Fejerman
Population structure of the 951 patients with breast cancer of the LACRN-MPBCS cohort included in this study. A, ADMIXTURE ancestry estimations obtained assuming four ancestral components for each country of origin (B) Principal component analysis (PCA) of data from all LACRN-MPBCS patients (triangles) and 158 reference subjects (dots). The two principal components of variation are shown as PC1 and PC2. C and D, Boxplots showing the distribution of each ancestry component for the whole cohort and by country, respectively. Median ancestry and IQRs are depicted; whiskers extend up to 1.5 IQR. Values outside the inter-quartile range are shown as solid dots. AFR, African; EAS, East Asian; EUR, European; IA, Indigenous American.